Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan

Comment

Shih-Chieh Shao et al. J Patient Saf. 2021.

. 2021 Jan 1;17(1):e43-e44.

doi: 10.1097/PTS.0000000000000795.

No abstract available

Conflict of interest statement

The authors disclose no conflict of interest.

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. Gautret P, et al. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20. Int J Antimicrob Agents. 2020. Retraction in: Int J Antimicrob Agents. 2025 Jan;65(1):107416. doi: 10.1016/j.ijantimicag.2024.107416. PMID: 32205204 Free PMC article. Retracted. Clinical Trial.

1. Gautret P Lagier JC Parola P, et al. . Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56:105949. - PMC - PubMed
1. Liu M Caputi TL Dredze M, et al. . Internet searches for unproven COVID-19 therapies in the United States. JAMA Intern Med. 2020;180:1116–1118. - PMC - PubMed
1. Sanders JM Monogue ML Jodlowski TZ, et al. . Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;323:1824–1836. - PubMed
1. Shao SC Chan YY Kao Yang YH, et al. . The Chang gung research database-a multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan. Pharmacoepidemiol Drug Saf. 2019;28:593–600. - PubMed
1. Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. Lancet. 2010;376:1261–1271. - PMC - PubMed